NCT04091542View on ClinicalTrials.gov

Hyperventilation and Oxygenation to Prolong Breath Hold in Breast Cancer Irradiation Treatment

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 15, 2019

Primary Completion Date

December 31, 2019

Study Completion Date

February 22, 2021

Conditions
Breast Cancer
Interventions
DEVICE

Optiflow/Ventilator

Participants will have 2 days with optiflow, 2 days with ventilator.

Trial Locations (1)

9000

University Hospital - Radiotherapy Department, Ghent

All Listed Sponsors
lead

University Hospital, Ghent

OTHER

NCT04091542 - Hyperventilation and Oxygenation to Prolong Breath Hold in Breast Cancer Irradiation Treatment | Biotech Hunter | Biotech Hunter